STAQ Pharma, Inc.

6 FDA enforcement actions

6 Total Recalls

2 Class I

1 Class II

3 Class III

Firm Details

Product Types: drug
States: CO

All Recalls

Class III: Low Risk 10/09/2025 drug

Labeling: Incorrect or Missing Lot and/or Exp Date
Class III: Low Risk 10/09/2025 drug

Labeling: Incorrect or Missing Lot and/or Exp Date
Class III: Low Risk 10/09/2025 drug

Labeling: Incorrect or Missing Lot and/or Exp Date
Class II: Risk 11/29/2023 drug

STAQ Pharma Inc. received consumer complaints related to leaking bags and other potential bag concerns. Upon investigation, they determine the source of the issue was with the bag manufacturer who released bags Lot # 134142-001A which had failed internal QC tests for leaks.
Class I: Dangerous 02/03/2022 drug

Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221A
Class I: Dangerous 02/03/2022 drug

Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221A

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.